Intellectual Property Portfolios

Traditional intellectual property rights do not exist in a vacuum. Your IP rights are intertwined with your contractual obligations, international laws, regulations and treaties, and your ability to enforce your rights -- and, yes, this is the short list.

Our attorneys also have experience helping our clients develop and enhance their IP portfolios by obtaining patents, trademarks, and copyrights in the U.S. and throughout the world.  We have almost two decades of experience obtaining patents from the U.S. Patent & Trademark Office, and internationally under the Patent Cooperation Treaty.  We have also managed several international IP portfolios that include hundreds of patents, patent applications, trademarks, technology licenses, technology disclosures, Drug Master Files (“DMFs”) and trade secrets.

Biotech patent attorney Kevin Buckley has developed IP portfolios having significant value. The underlying technologies include:

  • single molecule detection and counting
  • small molecule pharmaceuticals
  • bioequivalent molecules
  • polynucleotide and polypeptide variants
  • human cellular therapies
  • agriculture and plant-based technologies
  • human implant and medical device technologies

We have also assisted with regulatory filings including IND, NDA, ANDA, PMA, 510(k), standards organizations (IEEE, ASME, ISO, etc.) and other intangible assets which can be leveraged in a transaction.

Regardless of the extent of your technology platform, our attorneys have a combined thirty years experience assisting clients with leveraging the entire spectrum of the IP rights, whether in friendly or contested matters.